Targeting Interleukin-1 in Heart Failure and Inflammatory Heart Disease

Heart failure (HF) is a clinical syndrome characterized by dyspnea, fatigue, and poor exercise capacity due to insufficient cardiac function. HF represents the leading cause of hospitalization among adult patients over 65 years of age. Neurohormonal blockade has improved clinical outcomes; however,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current heart failure reports 2015-02, Vol.12 (1), p.33-41
Hauptverfasser:	Van Tassell, Benjamin W., Raleigh, Juan M. Valle, Abbate, Antonio
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiac Surgery Cardiology Cardiovascular Agents - therapeutic use Heart Failure - drug therapy Heart Failure - etiology Heart Failure - physiopathology Humans Imaging Inflammation Mediators - antagonists & inhibitors Inflammation Mediators - physiology Interleukin 1 Receptor Antagonist Protein - therapeutic use Interleukin-1 - antagonists & inhibitors Interleukin-1 - physiology Internal Medicine Medicine Medicine & Public Health Myocardial Infarction - complications Myocarditis - drug therapy Myocarditis - physiopathology Pharmacologic Therapy (WHW Tang Radiology Section Editor Topical Collection on Pharmacologic Therapy Vascular Surgery Ventricular Remodeling - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!